Roche Holding AG (RHHVF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Basel, Switzerland. El CEO actual es Thomas Schinecker.
RHHVF tiene fecha de IPO 2009-02-13, 103,249 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $321.02B.
Roche Holding AG is a Swiss pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, infectious diseases, immunology, and respiratory conditions, serving patients globally. Through its diagnostics division, Roche provides in vitro diagnostic tests, instruments, and reagents for detecting diseases such as cancer, cardiovascular conditions, diabetes, and infectious diseases including COVID-19. The company also pursues innovative research collaborations, including partnerships focused on synthetic biology treatments for conditions like inflammatory bowel disease. As an integrated healthcare company, Roche combines its pharmaceutical innovation with diagnostic capabilities to address major healthcare challenges worldwide.
